Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV : Data from the COMBINE ‐2 study

Title: Effectiveness and safety of two‐drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV : Data from the COMBINE ‐2 study
Authors: Mussini, Cristina; Henegar, Cassidy; Assoumou, Lambert; de Wit, Stephane; Johnson, Margaret; Quiros‐Roldan, Eugenia; Kenyon, Chris; Deschanvres, Colin; Zucman, David; Post, Frank; Movahedi, Roya; Comi, Laura; Fox, Julie; Liegeon, Geoffrey; Martin, Charlotte; Edwards, Jonathan; Tiecco, Giorgio; Delforge, Marc; Ragone, Leigh; Jones, Bryn; van Wyk, Jean; Aboud, Michael; Fletcher, Carl; Pozniak, Anton; Vannappagari, Vani
Contributors: Mussini, Cristina; Henegar, Cassidy; Assoumou, Lambert; De Wit, Stephane; Johnson, Margaret; Quiros‐roldan, Eugenia; Kenyon, Chri; Deschanvres, Colin; Zucman, David; Post, Frank; Movahedi, Roya; Comi, Laura; Fox, Julie; Liegeon, Geoffrey; Martin, Charlotte; Edwards, Jonathan; Tiecco, Giorgio; Delforge, Marc; Ragone, Leigh; Jones, Bryn; Van Wyk, Jean; Aboud, Michael; Fletcher, Carl; Pozniak, Anton; Vannappagari, Vani
Publication Year: 2026
Collection: Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS)
Subject Terms: dolutegravir/lamivudine; dolutegravir/rilpivirine; integrase inhibitor; two‐drug regimens
Description: Objectives: This study assessed real-world effectiveness and safety of switching to dual therapy regimens consisting of an integrase inhibitor (INSTI), and reverse transcriptase inhibitor (RTI), among suppressed people living with HIV in Europe. Methods: This observational cohort enrolled adults with HIV from 28 sites across Europe who were switching to a two-drug regimen of an INSTI plus a nucleoside reverse transcriptase inhibitor or non-nucleoside reverse transcriptase inhibitor while suppressed [viral load (VL)
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/41498461; info:eu-repo/semantics/altIdentifier/wos/WOS:001655582700001; firstpage:1; lastpage:13; journal:HIV MEDICINE; https://hdl.handle.net/11380/1396092
DOI: 10.1111/hiv.70187
Availability: https://hdl.handle.net/11380/1396092; https://doi.org/10.1111/hiv.70187
Rights: info:eu-repo/semantics/openAccess ; license:[IR] creative-commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.1C767E
Database: BASE